Aug 13, 2020
DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference
May 18, 2020
Biohaven Showcases Clinical and Pharmacoeconomic Data for NURTEC(TM) ODT (rimegepant) with 25 Presentations on the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Platform
May 08, 2020
Higher investigational doses of Trulicity® (dulaglutide) meaningfully reduced A1C and body weight in people with type 2 diabetes
Jun 17, 2019
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH
Mar 23, 2019
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO
Dec 06, 2018
Clinical trial sheds new light on potential risk associated with intravenous iron treatment
Nov 21, 2018
Pulmatrix Announces Positive Final Results from the Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE(TM) Formulation of Itraconazole
Nov 09, 2018
NGM Bio Announces New Histology Data from Phase 2 Trial of NGM282 in Patients with NASH
Aug 20, 2018
/R E P E A T -- Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution/
Jul 10, 2018
Update - Advisory - Several drugs containing valsartan being recalled due to contamination with a potential carcinogen
Jul 09, 2018
Advisory - Several drugs containing valsartan being recalled due to contamination with a potential carcinogen
Jun 25, 2018
Pulmatrix Announces Positive Top-Line Results from Parts 1 and 2 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE(TM) Formulation of Itraconazole
Jun 05, 2018
Sea-Land Chemical Company and Evonik Corporation Reach Distribution Agreement for Nutrition and Care Products
Mar 06, 2018
Axiom Foods Awarded First ‘Method of Use’ Patent for Oryzatein® Rice Protein
Feb 15, 2018
Sealed Air Announces Price Increases for Its North American Product Care Products
Nov 01, 2017
AltemiaTM Achieves Successful Clinical Results in Pediatric Patients with Sickle Cell Disease (SCD)
Oct 30, 2017
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid®
Sep 05, 2017
Lannett Receives Approval For Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg And 40 mg
Jun 10, 2017
Sotagliflozin Data from Pivotal inTandem1 and inTandem2 Studies in Patients with Type 1 Diabetes Presented at ADA 2017